Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors Meeting Abstract
| Authors: | O'Day, S.; Perez, C.; Wise-Draper, T.; Hanna, G.; Bhatia, S.; Kelly, C.; Medina, T.; Laux, D.; Daud, A.; Chandra, S.; Shaheen, M.; Gao, L.; Burgess, M.; Hernandez-Aya, L.; Yeung, C.; Smythe, K.; DeGoma, E.; Daniel, W.; Feltner, D.; Sindelar, L.; Michel, R.; Bexon, A.; Bexon, M.; Milhem, M. |
| Abstract Title: | Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A257 |
| End Page: | A258 |
| Language: | English |
| ACCESSION: | WOS:000616665300412 |
| DOI: | 10.1136/jitc-2020-SITC2020.0423 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 423 -- Source: Wos |
